Literature DB >> 15726312

[Is the prostate cancer screening behaviour of men with familial predisposition predictable?].

T Paiss1, D Kahn, R Küfer, C Maier, W Vogel, J E Gschwend, R E Hautmann, K Herkommer.   

Abstract

Little is known about the motives of German men to attend or refuse preventive checkups for prostate cancer. The aims of this study were to investigate if in men with familial predisposition screening behaviours are influenced by epidemiological or clinical parameters of prostate cancer of their affected relatives. 476 probands with one and 312 probands with at least two affected relatives were advised in writing to have a PSA-test and DRE done at their local urologists. We evaluated if the response rate was correlated to the proband's age, to the number and the age of onset of their affected relatives and also to the clinical course of their disease. Our data implicate that in men with familial predisposition the acceptance of prostate cancer screening is influenced only by individual characteristics and personal attitude and not by factors within the family. To which extent the awareness of disease risk is modified by familial predisposition remains to be evaluated.

Entities:  

Mesh:

Year:  2005        PMID: 15726312     DOI: 10.1007/s00120-005-0780-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  18 in total

1.  Informed consent for prostate-specific antigen-based screening--European view.

Authors:  Kazuto Ito; Fritz H Schrder
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

2.  Effect of fear-arousing communications.

Authors:  I L JANIS; S FESHBACH
Journal:  J Abnorm Psychol       Date:  1953-01

3.  American College of Preventive Medicine practice policy. Screening for prostate cancer in American men.

Authors:  R Ferrini; S H Woolf
Journal:  Am J Prev Med       Date:  1998-07       Impact factor: 5.043

4.  Demographic predictors of participation in free prostate cancer screening.

Authors:  M S Tingen; S P Weinrich
Journal:  Nurse Pract       Date:  1997-01

5.  Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.

Authors:  O J Austin; S Valente; L A Hasse; J R Kues
Journal:  Arch Fam Med       Date:  1997 Sep-Oct

6.  Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

Authors: 
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

7.  Why do men refuse or attend population-based screening for prostate cancer?

Authors:  H G Nijs; M L Essink-Bot; H J DeKoning; W J Kirkels; F H Schröder
Journal:  J Public Health Med       Date:  2000-09

8.  Impact of undergoing prostate carcinoma screening on prostate carcinoma-related knowledge and distress.

Authors:  Kathryn L Taylor; Rebecca Shelby; Jon Kerner; William Redd; John Lynch
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

9.  Awareness of prostate cancer among the general public: findings of an independent international survey.

Authors:  Claude C Schulman; Roger Kirby; John M Fitzpatrick
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

10.  Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients.

Authors:  Susan Thomas Vadaparampil; Paul B Jacobsen; Kathryn Kash; Iryna S Watson; Raoul Saloup; Julio Pow-Sang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

View more
  2 in total

Review 1.  [Familial prostate cancer and genetic predisposition].

Authors:  V H Meissner; M Jahnen; K Herkommer
Journal:  Urologe A       Date:  2021-03-15       Impact factor: 0.639

2.  [Prospective evaluation of prostate cancer screening in men with a family history of the disease].

Authors:  T Paiss; K Herkommer; D Kahn; J E Gschwend; R Küfer; C Maier; W Vogel; J Högel; R E Hautmann
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.